March 25, 2025
Epigenetic Markers May Predict Glaucoma Progression
A recent study finds that epigenetic age acceleration is linked to worsening disease.
2025 American Glaucoma Society Meeting
Related Articles
March 21, 2025
Green Strategies for Glaucoma Surgery
Thoughtful choices in the operating room can make health care more environmentally and economically sustainable.
March 19, 2025
Laser-Titratable Shunt Shows Promise in Feasibility Study
Three-month data presented at AGS suggests the Calibreye system may offer significant IOP and medication reduction with potential for in-office adjustments as needed.
March 6, 2025
Nicox Releases NCX 470 Data
Results of a post hoc analysis of the Mont Blanc trial, reported at AGS, found that the investigational drug formulation compared favorably to latanoprost.
March 5, 2025
Innovative Goggles Offer Drug-free IOP Control
The FYSX Ocular Pressure Adjusting Pump is the first nonpharmacological, nonsurgical glaucoma treatment approved by the FDA.
March 5, 2025
Six-year LiGHT Data Reviewed at AGS
The landmark study found that early SLT provides effective pressure control with less disease progression and fewer surgeries.
March 4, 2025
AGS Recommends Cautious Approach to Nicotinamide
Although nicotinamide, an over-the-counter supplement, remains intriguing as a potential neuroprotective agent for glaucoma, more research is needed to verify its long-term safety at higher doses.
March 4, 2025
MIGS Effective for Black Patients
Minimally invasive glaucoma surgeries can lower IOP effectively even among Black patients, who typically have more advanced disease.
March 3, 2025
Ultrathin Shunt Shows Promising Results in Trial
In interim data presented at AGS, the VisiPlate glaucoma drainage device demonstrated significant IOP and medication reductions with a favorable safety profile.
March 3, 2025
Restoring Access to Uveoscleral Outflow
Two-year data from the CREST trial, presented at AGS, shows a statistically significant reduction in IOP and medications.
February 27, 2025
Alcon Introduces Voyager DSLT at AGS
The automated Nd:YAG laser for direct selective laser trabeculoplasty is now commercially available in the United States.